Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: The SAKK experience
- 31 December 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (13), 2126-2128
- https://doi.org/10.1016/s0959-8049(98)00262-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chemotherapy for advanced gastric cancer: where do we stand?Journal of Clinical Oncology, 1997
- Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.Journal of Clinical Oncology, 1997
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of Clinical Oncology, 1997
- 546 Advanced gastric cancer: Comparison of FAMTX (5FU, adriamycine, methotrexate) versus elf (etroposide, 5 FU, leucovorin) versus FUP (infusional 5 FU+cisplatin). Results from an eortc trial of the GITCCG and the arbeitsgemeinschaft für innere onkologie (AIO)European Journal Of Cancer, 1995
- Early versus late alternating chemotherapy in small-cell lung cancerAnnals of Oncology, 1995
- Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials GroupBritish Journal of Cancer, 1994
- Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric CancerAmerican Journal of Clinical Oncology, 1991
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989